Northern Trust’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,407,438
| Closed | -$73.9M | – | 4477 |
|
|
2020
Q3 | $73.9M | Sell |
1,407,438
-178,920
| -11% | -$7.41M | 0.02% | 690 |
|
|
2020
Q2 | $52.8M | Buy |
1,586,358
+86,576
| +6% | +$2.76M | 0.01% | 853 |
|
|
2020
Q1 | $40.8M | Buy |
1,499,782
+159,771
| +12% | +$4.45M | 0.01% | 886 |
|
|
2019
Q4 | $26.4M | Buy |
1,340,011
+20,476
| +2% | +$327K | 0.01% | 1502 |
|
|
2019
Q3 | $17.1M | Buy |
1,319,535
+44,062
| +3% | +$532K | ﹤0.01% | 1797 |
|
|
2019
Q2 | $15.9M | Buy |
1,275,473
+11,012
| +0.9% | +$146K | ﹤0.01% | 1846 |
|
|
2019
Q1 | $18.4M | Buy |
1,264,461
+205,559
| +19% | +$2.63M | ﹤0.01% | 1766 |
|
|
2018
Q4 | $11.7M | Buy |
1,058,902
+47,369
| +5% | +$659K | ﹤0.01% | 1967 |
|
|
2018
Q3 | $26.6M | Buy |
1,011,533
+24,665
| +2% | +$667K | 0.01% | 1549 |
|
|
2018
Q2 | $20.2M | Buy |
986,868
+64,124
| +7% | +$1.38M | 0.01% | 1773 |
|
|
2018
Q1 | $16.7M | Buy |
922,744
+4,018
| +0.4% | +$67K | ﹤0.01% | 1821 |
|
|
2017
Q4 | $12.8M | Buy |
918,726
+6,912
| +0.8% | +$93.4K | ﹤0.01% | 2023 |
|
|
2017
Q3 | $16.9M | Buy |
911,814
+7,576
| +0.8% | +$127K | ﹤0.01% | 1828 |
|
|
2017
Q2 | $15.3M | Buy |
904,238
+97,893
| +12% | +$1.49M | ﹤0.01% | 1885 |
|
|
2017
Q1 | $10.8M | Buy |
806,345
+31,289
| +4% | +$490K | ﹤0.01% | 2071 |
|
|
2016
Q4 | $11.7M | Buy |
775,056
+24,823
| +3% | +$328K | ﹤0.01% | 2004 |
|
|
2016
Q3 | $8.77M | Buy |
750,233
+10,292
| +1% | +$121K | ﹤0.01% | 2163 |
|
|
2016
Q2 | $7.99M | Sell |
739,941
-7,003
| -0.9% | -$72.3K | ﹤0.01% | 2166 |
|
|
2016
Q1 | $6.9M | Buy |
746,944
+9,377
| +1% | +$101K | ﹤0.01% | 2212 |
|
|
2015
Q4 | $10.9M | Buy |
737,567
+18,293
| +3% | +$306K | ﹤0.01% | 1955 |
|
|
2015
Q3 | $11.8M | Buy |
719,274
+72,029
| +11% | +$1.47M | ﹤0.01% | 1869 |
|
|
2015
Q2 | $14.8M | Buy |
647,245
+67,998
| +12% | +$1.35M | ﹤0.01% | 1804 |
|
|
2015
Q1 | $8.8M | Buy |
579,247
+443
| +0.1% | +$5.76K | ﹤0.01% | 2151 |
|
|
2014
Q4 | $6.97M | Sell |
578,804
-11,633
| -2% | -$133K | ﹤0.01% | 2281 |
|
|
2014
Q3 | $6.7M | Sell |
590,437
-856
| -0.1% | -$9.76K | ﹤0.01% | 2314 |
|
|
2014
Q2 | $7.14M | Sell |
591,293
-72,232
| -11% | -$853K | ﹤0.01% | 2288 |
|
|
2014
Q1 | $7.73M | Sell |
663,525
-53,909
| -8% | -$913K | ﹤0.01% | 2287 |
|
|
2013
Q4 | $12.7M | Buy |
717,434
+860
| +0.1% | +$14.5K | ﹤0.01% | 1912 |
|
|
2013
Q3 | $10.3M | Sell |
716,574
-8,098
| -1% | -$124K | ﹤0.01% | 2014 |
|
|
2013
Q2 | $10.9M | Buy |
+724,672
| New | +$9.56M | ﹤0.01% | 1852 |
|
Northern Trust's MNTA Position: Q4 2020 in Review
Northern Trust sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,407,438 shares — an estimated $73.9M sold.
Northern Trust first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $73.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Northern Trust reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Northern Trust sold 1,407,438 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $73.9M.
- Northern Trust first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Northern Trust's Momenta Pharmaceuticals, Inc. position peaked at $73.9M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Northern Trust's 13F filing for Q4 2020, filed 11 Feb 2021.